세계의 외용 항진균제 시장 보고서(2025년)

Topical antifungals are medications intended for external application to treat fungal infections affecting the skin, nails, or mucous membranes. They work by either stopping fungal growth or eliminating the fungi altogether. These treatments are typically used for mild to moderate infections and help alleviate symptoms such as redness, itching, and swelling.

The key categories of topical antifungals include azoles, allylamines, echinocandins, and polyenes. Azoles act by blocking the synthesis of ergosterol, an essential component of fungal cell membranes. These drugs are available in various formulations such as creams, ointments, sprays, lotions, and powders. They are mainly used to address conditions like dermatophyte infections, candidiasis, tinea infections, and onychomycosis. Distribution channels include hospital pharmacies, retail drug stores, online pharmacies, and standard pharmacies, with end users spanning hospitals, clinics, pharmaceutical companies, and home healthcare providers.

The topical antifungals market research report is one of a series of new reports from The Business Research Company that provides topical antifungals market statistics, including the topical antifungals industry global market size, regional shares, competitors with the topical antifungals market share, detailed topical antifungals market segments, market trends, and opportunities, and any further data you may need to thrive in the topical antifungals industry. This topical antifungal market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The topical antifungals market size has grown strongly in recent years. It will grow from $5.64 billion in 2024 to $6.02 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. Growth during the historical period was driven by an increase in hospital-acquired infections, growing preference for topical treatments, rising incidence of aspergillus-related infections, higher demand for antifungal therapies, and a surge in diabetes prevalence.

The topical antifungals market size is expected to see strong growth in the next few years. It will grow to $7.74 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%.

The projected growth is fueled by worsening hygiene conditions and changing climatic factors, increasing rates of chronic illnesses, a growing elderly population, a surge in cases of vulvovaginal candidiasis, and rising occurrences of cryptococcosis. Key trends expected in the market include the development of advanced drug delivery platforms, adoption of more cost-effective and modern diagnostic solutions, the integration of artificial intelligence in drug development processes, and AI-driven fungal infection diagnostics.

The growing prevalence of skin diseases is anticipated to drive the expansion of the topical antifungals market in the coming years. Skin diseases encompass conditions that affect the skin's health, appearance, or function, such as irritation, inflammation, or infections. This increase in skin-related issues is largely attributed to greater exposure to environmental pollutants and ultraviolet (UV) radiation, both of which can harm the skin and trigger various disorders. Topical antifungals are used to treat these conditions by offering targeted action against fungal pathogens, minimizing systemic exposure, reducing adverse effects, and supporting faster healing of affected areas. For example, in April 2022, the American Journal of Managed Care, a US-based peer-reviewed journal, reported that 43% of 40,000 patients experienced at least one skin condition in the previous year. Additionally, in March 2023, the World Health Organization estimated that around 1.8 billion people worldwide are affected by skin conditions at any given time. As a result, the rising incidence of skin diseases is expected to propel the topical antifungals market.

Key players in the topical antifungals market are developing innovative treatments, including histone deacetylase (HDAC) inhibitors, to improve therapeutic outcomes, counter antifungal resistance, and enhance drug penetration in the nail bed for treating onychomycosis. HDAC inhibitors function by blocking histone deacetylase enzymes, which remove acetyl groups from histone proteins. For instance, in January 2024, Vanda Pharmaceuticals Inc., a US-based biotechnology firm, received FDA approval for its Investigational New Drug (IND) application to study VTR-297 as a treatment for onychomycosis, a prevalent fungal nail infection. VTR-297, a small-molecule HDAC inhibitor with antifungal properties, was originally derived from the bacterial species Streptomyces hygroscopicus and was first identified as an antifungal antibiotic.

In August 2022, Avista Capital Partners, a US-based private equity firm, acquired WellSpring Consumer Healthcare for an undisclosed sum. This acquisition was part of Avista's strategy to enhance its presence in the consumer healthcare market by utilizing WellSpring Consumer Healthcare's portfolio of over-the-counter (OTC) health and wellness products. WellSpring Consumer Healthcare specializes in the development of OTC medications and antifungal treatments.

Major players in the topical antifungals market are Pfizer Inc., Bayer AG, Novartis AG, GSK plc, Fresenius Kabi AG, Macleods Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd., Galderma S.A., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, LUPIN LIMITED, Zydus Cadila, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd, Taro Pharmaceutical Industries Ltd., Natco Pharma Ltd, Femcorp Pharma, Glamris Dermacare.

North America was the largest region in the topical antifungals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in topical antifungals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the topical antifungals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The topical antifungals market consists of sales of clotrimazole, terbinafine, ketoconazole, econazole, and tolnaftate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Topical Antifungals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on topical antifungals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for topical antifungals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The topical antifungals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Azoles; Allylamines; Echinocandins; Polyenes
• 2) By Formulation Type: Creams; Ointments; Lotions; Sprays; Powders
• 3) By Indication: Dermatophyte Infections; Candidiasis; Tinea Infections; Onychomycosis
• 4) By Distribution Channel: Pharmacies; Online Pharmacies; Hospital Pharmacies; Drug Stores
• 5) By End-User: Hospitals; Clinics; Home Healthcare; Pharmaceutical Companies
• Subsegments:
• 1) By Azoles: Clotrimazole; Miconazole; Ketoconazole; Fluconazole
• 2) By Allylamines: Terbinafine; Naftifine; Butenafine
• 3) By Echinocandins: Caspofungin; Micafungin; Anidulafungin
• 4) By Polyenes: Nystatin; Amphotericin B
• Companies Mentioned: Pfizer Inc.; Bayer AG; Novartis AG; GSK plc; Fresenius Kabi AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Topical Antifungals Market Characteristics

3. Topical Antifungals Market Trends And Strategies

4. Topical Antifungals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Topical Antifungals Growth Analysis And Strategic Analysis Framework

• 5.1. Global Topical Antifungals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Topical Antifungals Market Growth Rate Analysis
• 5.4. Global Topical Antifungals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Topical Antifungals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Topical Antifungals Total Addressable Market (TAM)

6. Topical Antifungals Market Segmentation

• 6.1. Global Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Azoles
• Allylamines
• Echinocandins
• Polyenes
• 6.2. Global Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Creams
• Ointments
• Lotions
• Sprays
• Powders
• 6.3. Global Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dermatophyte Infections
• Candidiasis
• Tinea Infections
• Onychomycosis
• 6.4. Global Topical Antifungals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacies
• Online Pharmacies
• Hospital Pharmacies
• Drug Stores
• 6.5. Global Topical Antifungals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Healthcare
• Pharmaceutical Companies
• 6.6. Global Topical Antifungals Market, Sub-Segmentation Of Azoles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clotrimazole
• Miconazole
• Ketoconazole
• Fluconazole
• 6.7. Global Topical Antifungals Market, Sub-Segmentation Of Allylamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Terbinafine
• Naftifine
• Butenafine
• 6.8. Global Topical Antifungals Market, Sub-Segmentation Of Echinocandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Caspofungin
• Micafungin
• Anidulafungin
• 6.9. Global Topical Antifungals Market, Sub-Segmentation Of Polyenes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nystatin
• Amphotericin B

7. Topical Antifungals Market Regional And Country Analysis

• 7.1. Global Topical Antifungals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Topical Antifungals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Topical Antifungals Market

• 8.1. Asia-Pacific Topical Antifungals Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Topical Antifungals Market

• 9.1. China Topical Antifungals Market Overview
• 9.2. China Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Topical Antifungals Market

• 10.1. India Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Topical Antifungals Market

• 11.1. Japan Topical Antifungals Market Overview
• 11.2. Japan Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Topical Antifungals Market

• 12.1. Australia Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Topical Antifungals Market

• 13.1. Indonesia Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Topical Antifungals Market

• 14.1. South Korea Topical Antifungals Market Overview
• 14.2. South Korea Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Topical Antifungals Market

• 15.1. Western Europe Topical Antifungals Market Overview
• 15.2. Western Europe Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Topical Antifungals Market

• 16.1. UK Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Topical Antifungals Market

• 17.1. Germany Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Topical Antifungals Market

• 18.1. France Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Topical Antifungals Market

• 19.1. Italy Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Topical Antifungals Market

• 20.1. Spain Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Topical Antifungals Market

• 21.1. Eastern Europe Topical Antifungals Market Overview
• 21.2. Eastern Europe Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Topical Antifungals Market

• 22.1. Russia Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Topical Antifungals Market

• 23.1. North America Topical Antifungals Market Overview
• 23.2. North America Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Topical Antifungals Market

• 24.1. USA Topical Antifungals Market Overview
• 24.2. USA Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Topical Antifungals Market

• 25.1. Canada Topical Antifungals Market Overview
• 25.2. Canada Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Topical Antifungals Market

• 26.1. South America Topical Antifungals Market Overview
• 26.2. South America Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Topical Antifungals Market

• 27.1. Brazil Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Topical Antifungals Market

• 28.1. Middle East Topical Antifungals Market Overview
• 28.2. Middle East Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Topical Antifungals Market

• 29.1. Africa Topical Antifungals Market Overview
• 29.2. Africa Topical Antifungals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Topical Antifungals Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Topical Antifungals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Topical Antifungals Market Competitive Landscape And Company Profiles

• 30.1. Topical Antifungals Market Competitive Landscape
• 30.2. Topical Antifungals Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GSK plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Topical Antifungals Market Other Major And Innovative Companies

• 31.1. Macleods Pharmaceuticals Ltd
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Galderma S.A.
• 31.4. Aurobindo Pharma Limited
• 31.5. Dr. Reddy's Laboratories
• 31.6. Cipla Limited
• 31.7. LUPIN LIMITED
• 31.8. Zydus Cadila
• 31.9. Glenmark Pharmaceuticals Ltd.
• 31.10. Alkem Laboratories Ltd.
• 31.11. Ipca Laboratories Ltd
• 31.12. Taro Pharmaceutical Industries Ltd.
• 31.13. Natco Pharma Ltd
• 31.14. Femcorp Pharma
• 31.15. Glamris Dermacare

32. Global Topical Antifungals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Topical Antifungals Market

34. Recent Developments In The Topical Antifungals Market

35. Topical Antifungals Market High Potential Countries, Segments and Strategies

• 35.1 Topical Antifungals Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Topical Antifungals Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Topical Antifungals Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer